Cite

HARVARD Citation

    Weitz, J. et al. (2019). Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis. Journal of thrombosis and haemostasis. pp. 2081-2088. [Online]. 
  
Back to record